Evidence That Ivermectin Suppresses Chlamydia trachomatis Infection in Epithelial Cells at Clinically Relevant Doses

Ivermectin is widely used to treat parasitic infections, but its effects on bacterial pathogens have remained largely unexplored. This study demonstrates that ivermectin inhibits infection and growth of Chlamydia trachomatis in epithelial cells. The findings reveal a previously unrecognized antibacterial activity and suggest that clinically achievable doses may have therapeutic potential for sexually transmitted and ocular chlamydial infections.


Read full article for free (open access):

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0048456

Microscopic or experimental analysis showing ivermectin-mediated inhibition of Chlamydia trachomatis infection and growth in epithelial cells compared with untreated controls.


Popular posts from this blog

Salivary microbiome diversity is associated with oral health and disease

Pacific has one of most successful years for grants in school history